Patients on Adcetris and chemo had better progression-free and overall survival after six years of follow-up compared to those on chemo only.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback